GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » E10

Synergy Pharmaceuticals (FRA:S90) E10 : €-0.65 (As of Sep. 2018)


View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Synergy Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2018 was €-0.120. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.65 for the trailing ten years ended in Sep. 2018.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-17), Synergy Pharmaceuticals's current stock price is €0.00. Synergy Pharmaceuticals's E10 for the quarter that ended in Sep. 2018 was €-0.65. Synergy Pharmaceuticals's Shiller PE Ratio of today is .


Synergy Pharmaceuticals E10 Historical Data

The historical data trend for Synergy Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals E10 Chart

Synergy Pharmaceuticals Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.65 -0.70

Synergy Pharmaceuticals Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.72 -0.70 -0.64 -0.69 -0.65

Competitive Comparison of Synergy Pharmaceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synergy Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's Shiller PE Ratio falls into.



Synergy Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Synergy Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2018 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2018 (Change)*Current CPI (Sep. 2018)
=-0.12/106.5067*106.5067
=-0.120

Current CPI (Sep. 2018) = 106.5067.

Synergy Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
200812 -0.037 88.697 -0.044
200903 -0.015 89.744 -0.018
200906 -0.021 91.003 -0.025
200909 -0.021 91.120 -0.025
200912 -0.027 91.111 -0.032
201003 -0.022 91.821 -0.026
201006 -0.057 91.962 -0.066
201009 -0.031 92.162 -0.036
201012 -0.060 92.474 -0.069
201103 -0.057 94.283 -0.064
201106 -0.069 95.235 -0.077
201109 -0.007 95.727 -0.008
201112 -0.084 95.213 -0.094
201203 -0.098 96.783 -0.108
201206 -0.135 96.819 -0.149
201209 -0.116 97.633 -0.127
201212 -0.137 96.871 -0.151
201303 -0.201 98.209 -0.218
201306 -0.083 98.518 -0.090
201309 -0.112 98.790 -0.121
201312 -0.161 98.326 -0.174
201403 -0.130 99.695 -0.139
201406 -0.206 100.560 -0.218
201409 -0.186 100.428 -0.197
201412 -0.260 99.070 -0.280
201503 -0.259 99.621 -0.277
201506 -0.303 100.684 -0.321
201509 -0.205 100.392 -0.217
201512 -0.248 99.792 -0.265
201603 -0.458 100.470 -0.486
201606 -0.205 101.688 -0.215
201609 -0.196 101.861 -0.205
201612 -0.294 101.863 -0.307
201703 -0.280 102.862 -0.290
201706 -0.294 103.349 -0.303
201709 -0.185 104.136 -0.189
201712 -0.135 104.011 -0.138
201803 -0.122 105.290 -0.123
201806 -0.103 106.317 -0.103
201809 -0.120 106.507 -0.120

Add all the adjusted EPS together and divide 10 will get our e10.


Synergy Pharmaceuticals  (FRA:S90) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Synergy Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Synergy Pharmaceuticals (FRA:S90) Business Description

Traded in Other Exchanges
N/A
Address
420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170
Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines